Mr. Christopher Blick

Mr Chris Blick is a Consultant Urological Surgeon who has a subspeciality interest in urological cancers, particularly laparoscopic and robotic renal, ureteric and bladder surgery. Mr Blick has an interest in the treatment of benign prostatic enlargement using rezum and urolift technology. Mr Chris Blick also has a particular interest in clinical trials. He was successful in becoming the first urological trainee member of the National Institute of Heath Research (NIHR) clinical studies group (CSG). He currently sits on the national renal and bladder cancer CSG, the screening and early prevention (SPED) group and the UK cancer screening and early prevention group of the NIHR. He is the Research and Development Lead in Urology at the Royal Berkshire Hospital. He has recently received funding and is Chief Investigator in the TARGET trial using augmented reality and artificial intelligence in the diagnosis of prostate cancer. He is also UK Chief Investigator for the EASE Trial examining the role of active surveillance in renal cancer.